Unhealthy behaviors and risk of uncontrolled hypertension among treated individuals-The CONSTANCES population-based study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 02 2020
Historique:
received: 02 08 2019
accepted: 19 12 2019
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 21 11 2020
Statut: epublish

Résumé

From an epidemiological standpoint, quantifying the individual and the combined effect of lifestyle factors on uncontrolled blood pressure (BP) deserves further evaluation. We aimed to examine the individual and combined associations between unhealthy behaviors and uncontrolled hypertension among treated hypertensive adults. Cross-sectional analysis was conducted using data from CONSTANCES, an ongoing French population-based cohort study. Uncontrolled BP was defined as mean systolic BP ≥140 mmHg and/or mean diastolic BP ≥90 mmHg. Unhealthy behaviors were considered as heavy alcohol consumption, low or medium adherence to dietary recommendations, sedentary physical activity level, and overweight. A total of 10,710 hypertensive treated volunteer participants were included and 56.1% had uncontrolled hypertension; of them, 2.0%, 24.5%, 54.0% and 19.5% exhibited 0, 1, 2 or ≥3 unhealthy behaviors respectively. In men, there was an increased odds of uncontrolled hypertension with heavy alcohol drinking compared to light-or-never (adjusted odds ratio 1.34, 95% CI 1.10-1.63), with low as well as with medium adherence to dietary recommendations compared to high (p < 0.05 for both), and with overweight or obesity compared to a normal body mass index (p ≤ 0.001 for both). In addition, men reporting a combination of ≥3 unhealthy behaviors compared to none, had an increased odds of hypertension of 1.67 (95% CI 1.09-2.53). Unhealthy behaviors described as, heavy alcohol consumption, non-adherence to dietary recommendations and overweight are associated with uncontrolled hypertension, at the individual and combined level, and particularly in men. Improvement of modifiable lifestyle factors could offer considerable benefits in the management of hypertension.

Identifiants

pubmed: 32024888
doi: 10.1038/s41598-020-58685-1
pii: 10.1038/s41598-020-58685-1
pmc: PMC7002708
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1925

Références

WHO. A global brief on Hypertension; Silent killer, global public health crisis, (World Heath Organisation, 2013).
Roger, V. L. et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 125, e2–e220 (2012).
doi: 10.1161/CIR.0b013e318245fac5
Centers for Disease Control and Prevention (CDC). Vital signs: awareness and treatment of uncontrolled hypertension among adults– United States, 2003–2010. MMWR Morb. Mortal. Wkly. Rep. 61, 703–709 (2012).
Wolf-Maier, K. et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43, 10–17 (2004).
doi: 10.1161/01.HYP.0000103630.72812.10
Perrine, A.-L., Lecoffre, C., Blacher, J. & Olié, V. L’hypertension artérielle en France: prévalence, traitement et contrôle en 2015 et évolution depuis 2006. Bull. Epidemiol. Hebd. 10, 170–179 (2018).
Banegas, J. R. et al. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension 43, 1338–1344 (2004).
doi: 10.1161/01.HYP.0000127424.59774.84
Lee, J. K., Grace, K. A. & Taylor, A. J. Effect of a pharmacy care program on medication adherence and persistence, blood pressure and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 296, 2563–2571 (2006).
doi: 10.1001/jama.296.21.joc60162
Corrao, G. et al. Discontinuation of and changes in drug therapy for hypertension among newly treated patients: a population-based study in Italy. J. Hypertens. 26, 819–824 (2008).
doi: 10.1097/HJH.0b013e3282f4edd7
Ham, O. K. & Yang, S. J. Lifestyle factors associated with blood pressure control among those taking antihypertensive medication. Asia Pac. J. Public. Health 23, 485–495 (2011).
doi: 10.1177/1010539509347941
Stern, L.N. & Subrahmanyam, M.G. Patient Adherence to the Dietary Approaches to Stop Hypertension (DASH) Diet for Non-Primary English Speakers. Thesis, New York University, USA, 2009.
Baena, C. P. et al. Effects of lifestyle-related interventions on blood pressure in low and middle-income countries: systematic review and meta-analysis. J. Hypertens. 32, 961–973 (2014).
doi: 10.1097/HJH.0000000000000136
Appel, L. J. et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 289, 2083–2093 (2003).
pubmed: 12709466
Whelton, P. K. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71, e13–e115 (2018).
pubmed: 29133356
Williams, B. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 39, 3021–3104 (2018).
doi: 10.1093/eurheartj/ehy339
Zins, M. et al. The CONSTANCES cohort: an open epidemiological laboratory. BMC Public. Health 10, 479 (2010).
doi: 10.1186/1471-2458-10-479
Lloyd-Jones, D. M. et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 36, 594–599 (2000).
doi: 10.1161/01.HYP.36.4.594
Cleroux, J., Feldman, R. D. & Petrella, R. J. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. CMAJ 160, S21–S28 (1999).
pubmed: 10333850 pmcid: 1230336
Papademetriou, V. & Kokkinos, P. F. The role of exercise in the control of hypertension and cardiovascular risk. Curr. Opin. Nephrol. Hypertens. 5, 459–462 (1996).
doi: 10.1097/00041552-199609000-00014
Paula, T. P. et al. Effects of the DASH Diet and Walking on Blood Pressure in Patients With Type 2 Diabetes and Uncontrolled Hypertension: A Randomized Controlled Trial. J. Clin. Hypertens. 17, 895–901 (2015).
doi: 10.1111/jch.12597
Appel, L. J. et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336, 1117–24 (1997).
doi: 10.1056/NEJM199704173361601
Ohira, T. et al. Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension 53, 13–19 (2009).
doi: 10.1161/HYPERTENSIONAHA.108.114835
Arkwright, P. D. et al. Effects of alcohol use and other aspects of lifestyle on blood pressure levels and prevalence of hypertension in a working population. Circulation 66, 60–66 (1982).
doi: 10.1161/01.CIR.66.1.60
Dickinson, H. O. et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J. Hypertens. 24, 215–233 (2006).
doi: 10.1097/01.hjh.0000199800.72563.26
Cherfan, M. et al. Unhealthy behavior and risk of hypertension: the CONSTANCES population-based cohort. J. Hypertens. 37, 2180–2189 (2019).
doi: 10.1097/HJH.0000000000002157
Farah, R. et al. Predictors of Uncontrolled Blood Pressure in Treated Hypertensive Individuals: First Population-Based Study in Lebanon. J. Clin. Hypertens. 18, 871–877 (2016).
doi: 10.1111/jch.12775
Leblanc, V. et al. Differences between men and women in dietary intakes and metabolic profile in response to a 12-week nutritional intervention promoting the Mediterranean diet. J. Nutr. Sci. 4, e13 (2015).
doi: 10.1017/jns.2015.2
Rosendo, I., Santiago, L. M. & Marques, M. Characteristics Associated with Uncontrolled Blood Pressure Among Portuguese Primary Care Patients with Type 2 Diabetes. Acta Med. Port. 30, 197–204 (2017).
doi: 10.20344/amp.8321
Choudhary, R., Sharma, S. M., Kumari, V. & Gautam, D. Awareness, treatment adherence and risk predictors of uncontrolled hypertension at a tertiary care teaching hospital in Western India. Indian. Heart J. 68, S251–S252 (2016).
doi: 10.1016/j.ihj.2016.08.003
Asgedom, S. W., Gudina, E. K. & Desse, T. A. Assessment of Blood Pressure Control among Hypertensive Patients in Southwest Ethiopia. PLoS ONE 11, e0166432 (2016).
doi: 10.1371/journal.pone.0166432
Primatesta, P., Falaschetti, E., Gupta, S., Marmot, M. G. & Poulter, N. R. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 37, 187–193 (2001).
doi: 10.1161/01.HYP.37.2.187
Wu, J. et al. A summary of the effect of the results of antihypertensive medications on measured blood pressure. Am. J. Hypertension 18, 935–942 (2005).
doi: 10.1016/j.amjhyper.2005.01.011
Zins, M. & Goldberg, M. & the CONSTANCES team. The French CONSTANCES population-based cohort: design, inclusion and follow-up. Eur. J. Epidemiol. 30, 1317–1328 (2015).
doi: 10.1007/s10654-015-0096-4
Ruiz, F. et al. High quality standards for a large-scale prospective population-based observational cohort: Constances. BMC Public. Health 16, 877 (2016).
doi: 10.1186/s12889-016-3439-5
Blacher, J. et al. Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam. Clin. Pharmacol. 28, 1–9 (2014).
doi: 10.1111/fcp.12044
Airagnes, G. et al. Job exposure to the public in relation with alcohol, tobacco and cannabis use: Findings from the CONSTANCES cohort study. PLoS One 13, e0196330 (2018).
doi: 10.1371/journal.pone.0196330
WHO. International Guide for Monitoring Alcohol Consumption and Related Harm, (World Health Organization, 2000)
Merle, B. M. J. et al. Unhealthy behaviours and risk of visual impairment: The CONSTANCES population-based cohort. Sci. Rep. 8, 6569 (2018).
doi: 10.1038/s41598-018-24822-0
Fung, T. T. et al. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 168, 713–720 (2008).
doi: 10.1001/archinte.168.7.713
Karanja, N.M. et al. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. J Am Diet Assoc 357, S19-S27 (1999).
doi: 10.1016/S0002-8223(99)00412-5
Schneider, S.L. The International Standard Classification of Education 2011. In Class and Stratification Analysis (Comparative Social Research, Volume 30). (ed. Birkelund, G. E.) 1st edn, 365–79, (Emerald Group Publishing Limited, Bingley, 2013).
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl. 7, 1–59 (2017).
doi: 10.1016/j.kisu.2017.04.001

Auteurs

Michelle Cherfan (M)

Nutritional Epidemiology Research Unit (EREN), Inserm U1153, Inra U1125, Cnam, Crnh, Paris 13 University Sorbonne Paris Cite, Bobigny, France.
Faculty of Pharmacy, Lebanese International University, Beirut, Lebanon.

Alexandre Vallée (A)

Faculty of Medicine, Paris-Descartes University, Paris, France.
Diagnosis and Therapeutic Center, Hypertension and Cardiovascular Prevention Unit, Hôtel-Dieu Hospital; AP-HP, Paris, France.

Sofiane Kab (S)

Population-based Epidemiological Cohorts Unit, Inserm, UMS011, Villejuif, France.

Pascale Salameh (P)

Faculty of Public Health, Lebanese University, Fanar, Lebanon.
Institut National de Santé Publique, Epidémiologie Clinique et Toxicologie (INSPECT-LB), Beirut, Lebanon.

Marcel Goldberg (M)

Faculty of Medicine, Paris-Descartes University, Paris, France.
Population-based Epidemiological Cohorts Unit, Inserm, UMS011, Villejuif, France.

Marie Zins (M)

Faculty of Medicine, Paris-Descartes University, Paris, France.
Population-based Epidemiological Cohorts Unit, Inserm, UMS011, Villejuif, France.

Jacques Blacher (J)

Nutritional Epidemiology Research Unit (EREN), Inserm U1153, Inra U1125, Cnam, Crnh, Paris 13 University Sorbonne Paris Cite, Bobigny, France. jacques.blacher@aphp.fr.
Faculty of Medicine, Paris-Descartes University, Paris, France. jacques.blacher@aphp.fr.
Diagnosis and Therapeutic Center, Hypertension and Cardiovascular Prevention Unit, Hôtel-Dieu Hospital; AP-HP, Paris, France. jacques.blacher@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH